Status:
COMPLETED
The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting
Lead Sponsor:
Västernorrland County Council, Sweden
Collaborating Sponsors:
Falu Hospital
University of Gavle
Conditions:
Breast Cancer
Colorectal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background: Chemotherapy-induced nausea and vomiting (CINV) is a common and burdensome side-effect of emetogenic chemotherapy. CINV affects both the patient's quality of life and induces high costs wi...
Detailed Description
Background: Chemotherapy-induced nausea and vomiting (CINV) is a common and burdensome side-effect of emetogenic chemotherapy. CINV affects both the patient's quality of life and induces high costs wi...
Eligibility Criteria
Inclusion
- Patients of at least 18 years of age
- Breast, colorectal, bladder, or testicular cancer
- Receiving adjuvant or neo-adjuvant intravenous chemotherapy inducing medium or high risk for emesis
- Willing and capable to give their informed consent and to take part of the treatment and data collection procedure
Exclusion
- Consumption of antiemetics or experiences of persistent nausea, which will persist within 24 hours prior to the start of the chemotherapy session
- Hemophilia
- Former participation in the same study
Key Trial Info
Start Date :
September 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 15 2025
Estimated Enrollment :
198 Patients enrolled
Trial Details
Trial ID
NCT03232541
Start Date
September 1 2017
End Date
August 15 2025
Last Update
August 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sundsvall Hospital
Sundsvall, Sweden, SE-85186